Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Density × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 94 Neoplasms 6 Neoplasm Metastasis 6 Arthralgia 4 Advanced Breast Cancer 4 Carcinoma, Intraductal, Noninfiltrating 3 Osteoporosis 2 Multiple Endocrine Neoplasia Type 1 2 Breast Neoplasms, Male 2 Breast Carcinoma In Situ 2 Breast Cancer Metastatic 2 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Seizures 1 Recurrence 1 Quality of Life 1 Pain 1 Obesity 1 Lethal Congenital Contracture Syndrome 2 1 Joint Diseases 1 Invasive Breast Cancer 1 Hypogonadism 1 Fractures, Bone 1 Erectile Dysfunction 1 Epilepsy 1 Bone Diseases, Metabolic 1 Bone Density 1 Advanced Metastatic Breast Cancer 1

Interventions

Tamoxifen 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

AstraZeneca

Phase 3 Completed

Bone Density

Data powered by HemOnc (CC BY 4.0) Colophon ⚡